ImmunityBio
IBRX
IBRX
61 hedge funds and large institutions have $9.95M invested in ImmunityBio in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.76% less ownership
Funds ownership: 13.59% → 10.83% (-2.8%)
75% less capital invested
Capital invested by funds: $39.8M → $9.95M (-$29.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
61
Holding in Top 10
–
Calls
$48K
Puts
$38K
Top Buyers
| 1 | +$437K | |
| 2 | +$270K | |
| 3 | +$162K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$157K |
| 5 |
HK
Horizon Kinetics
New York
|
+$139K |
Top Sellers
| 1 | -$9.85M | |
| 2 | -$950K | |
| 3 | -$132K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$101K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$63K |